Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by deepoil0808on Nov 20, 2021 4:41pm
101 Views
Post# 34149766

RE:Very Profitable Quarter: Details inside

RE:Very Profitable Quarter: Details insideSo where exactly is the surpised?

Everyone is so excited as if a major discovery was made.  

This is what I had posted on October 2nd, 2021 or almost 45 days before actual earnings report and NOW I AM TELLING YOU THAT THIS 4TH QUARTER WILL SHOW A MATERIAL DECLINE IN REVENUE + A LOSS FROM OPERATIONS.

This was my previous post:

Projected Revenue in Q3 ending September 30, 2021

Actual         1st week of July:                    $    1,005,050
Actual         2nd week of July:                         1,005,050
Actual         3rd week of July:                          1,005,050
Actual         4th week of July                           1,005,050
Estimate     1st week of August                       1,005,050
Estimate     2nd week of August                      1,005,050
Actual         3rd week of August                       3,015,150  (per lawyer reponse that revenues tripled)
Actual         4th week of August                       3,015,150
Actual         1st week of September                 3,015,150
Actual         2nd week of September                3,015,150
Actual         3rd week of September                 3,015,150
Actual         4th week of September                 3,015,150
TOTAL PROJECTED REVENUE:          $     22,111,100

Gross Margins                                                         40%    (doing all 3 tests, margins are much higher)

Gross Profit:                                                       8,444,400

Expenses in quarter:                                          3,400,000

Net Profit:                                                $        5,444,400

My personal opinion
<< Previous
Bullboard Posts
Next >>